234 related articles for article (PubMed ID: 30700214)
1. Factors predictive of long-term mortality in lupus nephritis: a multicenter retrospective study of a Japanese cohort.
Ichinose K; Kitamura M; Sato S; Fujikawa K; Horai Y; Matsuoka N; Tsuboi M; Nonaka F; Shimizu T; Fukui S; Umeda M; Koga T; Kawashiri S; Iwamoto N; Tamai M; Nakamura H; Origuchi T; Nishino T; Kawakami A
Lupus; 2019 Mar; 28(3):295-303. PubMed ID: 30700214
[TBL] [Abstract][Full Text] [Related]
2. Complete renal response at 12 months after induction therapy is associated with renal relapse-free rate in lupus nephritis: a single-center, retrospective cohort study.
Ichinose K; Kitamura M; Sato S; Eguchi M; Okamoto M; Endo Y; Tsuji S; Takatani A; Shimizu T; Umeda M; Fukui S; Sumiyoshi R; Koga T; Kawashiri S; Iwamoto N; Igawa T; Tamai M; Nakamura H; Origuchi T; Nishino T; Kawakami A
Lupus; 2019 Apr; 28(4):501-509. PubMed ID: 30755146
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Lupus Nephritis Induction Treatments in a Hispanic Population: A Single-center Cohort Analysis.
Mejía-Vilet JM; Arreola-Guerra JM; Córdova-Sánchez BM; Morales-Buenrostro LE; Uribe-Uribe NO; Correa-Rotter R
J Rheumatol; 2015 Nov; 42(11):2082-91. PubMed ID: 26373566
[TBL] [Abstract][Full Text] [Related]
4. Comparison of complete renal response and mortality in early- and late-onset lupus nephritis: a multicenter retrospective study of a Japanese cohort.
Ichinose K; Kitamura M; Sato S; Fujikawa K; Horai Y; Matsuoka N; Tsuboi M; Nonaka F; Shimizu T; Sumiyoshi R; Koga T; Kawashiri SY; Iwamoto N; Igawa T; Tamai M; Nakamura H; Origuchi T; Nishino T; Kawakami A
Arthritis Res Ther; 2020 Jul; 22(1):175. PubMed ID: 32698892
[TBL] [Abstract][Full Text] [Related]
5. Podocyte foot process width is a prediction marker for complete renal response at 6 and 12 months after induction therapy in lupus nephritis.
Ichinose K; Kitamura M; Sato S; Fujikawa K; Horai Y; Matsuoka N; Tsuboi M; Nonaka F; Shimizu T; Fukui S; Umeda M; Koga T; Kawashiri SY; Iwamoto N; Igawa T; Tamai M; Nakamura H; Origuchi T; Nishino T; Kawakami A
Clin Immunol; 2018 Dec; 197():161-168. PubMed ID: 30296591
[TBL] [Abstract][Full Text] [Related]
6. Chronicity index, especially glomerular sclerosis, is the most powerful predictor of renal response following immunosuppressive treatment in patients with lupus nephritis.
Park DJ; Choi SE; Xu H; Kang JH; Lee KE; Lee JS; Choi YD; Lee SS
Int J Rheum Dis; 2018 Feb; 21(2):458-467. PubMed ID: 29314776
[TBL] [Abstract][Full Text] [Related]
7. Combination immunosuppressant therapy and lupus nephritis outcome: a hospital-based study.
Chen YM; Hung WT; Liao YW; Hsu CY; Hsieh TY; Chen HH; Hsieh CW; Lin CT; Lai KL; Tang KT; Tseng CW; Huang WN; Chen YH
Lupus; 2019 Apr; 28(5):658-666. PubMed ID: 30971165
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological findings, treatment response and predictors of long-term outcome in a cohort of lupus nephritis patients managed according to the Euro-lupus regime: a retrospective analysis in Sri Lanka.
Herath N; Ratnatunga N; Weerakoon K; Wazil A; Nanayakkara N
BMC Res Notes; 2017 Feb; 10(1):80. PubMed ID: 28148285
[TBL] [Abstract][Full Text] [Related]
9. Outcome of lupus nephritis in childhood onset SLE in North and Central India: single-centre experience over 25 years.
Srivastava P; Abujam B; Misra R; Lawrence A; Agarwal V; Aggarwal A
Lupus; 2016 Apr; 25(5):547-57. PubMed ID: 26637291
[TBL] [Abstract][Full Text] [Related]
10. Renal Remission Status and Longterm Renal Survival in Patients with Lupus Nephritis: A Retrospective Cohort Analysis.
Davidson JE; Fu Q; Ji B; Rao S; Roth D; Magder LS; Petri M
J Rheumatol; 2018 May; 45(5):671-677. PubMed ID: 29496892
[TBL] [Abstract][Full Text] [Related]
11. Correlation between the clinical remission and histological remission in repeat biopsy findings of quiescent proliferative lupus nephritis.
Das U; Patel R; Guditi S; Taduri G
Lupus; 2021 May; 30(6):876-883. PubMed ID: 33611965
[TBL] [Abstract][Full Text] [Related]
12. Delayed lupus nephritis in the course of systemic lupus erythematosus is associated with a poorer treatment response: a multicentre, retrospective cohort study in Japan.
Nakano M; Kubo K; Shirota Y; Iwasaki Y; Takahashi Y; Igari T; Inaba Y; Takeshima Y; Tateishi S; Yamashita H; Miyazaki M; Sato H; Kanda H; Kaneko H; Ishii T; Fujio K; Tanaka N; Mimori A
Lupus; 2019 Aug; 28(9):1062-1073. PubMed ID: 31296139
[TBL] [Abstract][Full Text] [Related]
13. Effect of complete or partial proteinuria recovery on long-term outcomes of lupus nephritis.
Medina-Rosas J; Fung WA; Su J; Touma Z
Semin Arthritis Rheum; 2018 Feb; 47(4):557-564. PubMed ID: 28888363
[TBL] [Abstract][Full Text] [Related]
14. Impact of stringent response in proteinuria on long-term renal outcomes in proliferative lupus nephritis.
Won J; Lee JS; Oh JS; Kim YG; Lee CK; Yoo B; Hong S
Lupus; 2019 Oct; 28(11):1294-1301. PubMed ID: 31583978
[TBL] [Abstract][Full Text] [Related]
15. Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis.
Moroni G; Vercelloni PG; Quaglini S; Gatto M; Gianfreda D; Sacchi L; Raffiotta F; Zen M; Costantini G; Urban ML; Pieruzzi F; Messa P; Vaglio A; Sinico RA; Doria A
Ann Rheum Dis; 2018 Sep; 77(9):1318-1325. PubMed ID: 29730634
[TBL] [Abstract][Full Text] [Related]
16. Retrospective analysis of nephritis response and renal outcome in a cohort of 928 Egyptian lupus nephritis patients: a university hospital experience.
Momtaz M; Fayed A; Wadie M; Gamal SM; Ghoniem SA; Sobhy N; Kamal Elden NM; Hamza WM
Lupus; 2017 Dec; 26(14):1564-1570. PubMed ID: 28625079
[TBL] [Abstract][Full Text] [Related]
17. Remission of proteinuria indicates good prognosis in patients with diffuse proliferative lupus nephritis.
Koo HS; Kim S; Chin HJ
Lupus; 2016 Jan; 25(1):3-11. PubMed ID: 26159540
[TBL] [Abstract][Full Text] [Related]
18. A descriptive study of the factors associated with damage in Malaysian patients with lupus nephritis.
Shaharir SS; Ghafor AH; Said MS; Kong NC
Lupus; 2014 Apr; 23(4):436-42. PubMed ID: 24399814
[TBL] [Abstract][Full Text] [Related]
19. Lack of partial renal response by 12 weeks after induction therapy predicts poor renal response and systemic damage accrual in lupus nephritis class III or IV.
Hanaoka H; Yamada H; Kiyokawa T; Iida H; Suzuki T; Yamasaki Y; Ooka S; Nagafuchi H; Okazaki T; Ichikawa D; Shirai S; Shibagaki Y; Koike J; Ozaki S
Arthritis Res Ther; 2017 Jan; 19(1):4. PubMed ID: 28086993
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes with multi-targeted immunosuppressive protocol in children with severe proliferative lupus nephritis.
Aragon E; Resontoc LP; Chan YH; Lau YW; Tan PH; Loh HL; Ng KH; Yap HK
Lupus; 2016 Apr; 25(4):399-406. PubMed ID: 26537422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
